Skip to main content
Log in

Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE Protocol

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Hematopoietic stem cell transplantation is curative therapy in benign and malignant diseases. Adequate stem cell dose is one of the most important marker of engraftment. Several methods have been developed to enumerate CD34+ cells. We present our data on 147 samples analysis. There was a clear linear correlation between two methods. Both methods were effective. Both single vs dual platform analysis yield similar results. Single platform analysis is easier to perform. In terms of cost reduction dual platform analysis is better.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Allan DS, Keeney M, Howson-Jan K et al (2002) Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 29(12):967–972

    Article  CAS  PubMed  Google Scholar 

  2. Ngoma A, Saito S, Ohto H, Ikeda K, Yasuda H, Kawabata K, Kanno T, Kikuta A, Mochizuki K, Nollet KE (2011) CD34+ cell enumeration by flow cytometry: a comparison of systems and methodologies. Arch Pathol Lab Med 135(7):909–914

    PubMed  Google Scholar 

  3. Fritsch G, Stimpfl M, Kurz M et al (1996) The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 17(2):169–178

    CAS  PubMed  Google Scholar 

  4. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR (1998) Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines; International Society of Hematotherapy and Graft Engineering. Cytometry 34(2):61–70

    Article  CAS  PubMed  Google Scholar 

  5. Chapple P, Prince HM, Wall D, Filshie R, Haylock D, Quinn M, Bretell M, Venter D (2000) Comparison of three methods of CD34+ cell enumeration in peripheral blood: dual-platform ISHAGE protocol versus single-platform, versus microvolume fluorimetry. Cytotherapy 2(5):371–376

    Article  CAS  PubMed  Google Scholar 

  6. Barbosa IL, Sousa ME, Godinho MI, Sousa F, Carvalhais A (1999) Single-versus dual-platform assays for human CD34 cell enumeration. Cytometry 38:274–279

    Article  CAS  PubMed  Google Scholar 

  7. Gratama JW, Orfao A, Barnett D et al (1998) Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells; European Working Group on Clinical Cell Analysis. Cytometry 34(3):128–142

    Article  CAS  PubMed  Google Scholar 

  8. Chin-Yee I, Anderson L, Keeney M, Sutherland DR (1997) Quality assurance of stem cell enumeration by flow cytometry; Canadian QASE Study Group. Cytometry 30(6):296–303

    Article  CAS  PubMed  Google Scholar 

  9. Mercolino TJ, Connelly MC, Meyer EJ et al (1995) Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry 22(1):48–59

    Article  CAS  PubMed  Google Scholar 

  10. Strauss K, Hannet I, Engels S et al (1996) Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. Cytometry 26(1):52–59

    Article  CAS  PubMed  Google Scholar 

  11. Chang A, Ma DDF (1997) The influence of flow cytometric gat- ing strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. J Hematother 5:605–616

    Article  Google Scholar 

  12. Robinson G, Morgan L, Evans M et al (1992) Effect of type of haematology analyser on CD4 count. Lancet 340(8817):485

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the help of Ms. Kavita from CMC Vellore for statistical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rahul Naithani.

Ethics declarations

Conflict of interest

We have no financial relationships to disclose.

Informed Consent

Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naithani, R., Dayal, N. & Dixit, G. Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE Protocol. Indian J Hematol Blood Transfus 33, 370–374 (2017). https://doi.org/10.1007/s12288-016-0749-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-016-0749-9

Keywords

Navigation